Images

Filter by

Figure 2 Kaplan–Meier Curves Comparing Survival Free of the Primary Endpoint Death From Any Cause or Admission for Worsening Heart Failure and its Two Components in the Catheter Ablation and Medical Treatment Groups in CASTLE AF
Figure 2: Kaplan–Meier Curves Comparing Survival Free of the Primary Endpoint (Death From Any Cause) or Admission for Worsening Heart Failure) and its Two Components in the Catheter Ablation and Medical Treatment Groups in CASTLE-AF
Table 2 Landmark Trials for Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure and Reduced Ejection Fraction
Table 2: Landmark Trials for Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure and Reduced Ejection Fraction
Table 1 Landmark Trials for Pharmacological Rhythm Control of Atrial Fibrillation in Patients with Heart Failure and Reduced Ejection Fraction
Table 1: Landmark Trials for Pharmacological Rhythm Control of Atrial Fibrillation in Patients with Heart Failure and Reduced Ejection Fraction
Figure 1 Current Guideline Recommendation for Management of AF in Patients with HFrEF
Figure 1: Current Guideline Recommendation for Management of AF in Patients with HFrEF
Figure 1 Atrial Late gadolinium Enhancement on Cardiac MRI and Corresponding 3D Shells Demonstrating Regions of Scar
Figure 1: Atrial Late-gadolinium Enhancement on Cardiac MRI and Corresponding 3D Shells Demonstrating Regions of Scar
Table 1 Randomised Controlled Trials of Catheter Ablation for the Treatment of Atrial Fibrillation in Patients with Heart Failure Published Within the Past 10 Years
Table 1: Randomised Controlled Trials of Catheter Ablation for the Treatment of Atrial Fibrillation in Patients with Heart Failure Published Within the Past 10 Years
Table 2 Association of Dietary Components with the Incidence and Severity of Heart Failure
Table 2: Association of Dietary Components with the Incidence and Severity of Heart Failure
Table 1 Association of Foods with Heart Failure Incidence and Severity
Table 1: Association of Foods with Heart Failure Incidence and Severity
Figure 2 Interaction of Heart Failure HF and Central Sleep Apnoea CSA
Figure 2: Interaction of Heart Failure (HF) and Central Sleep Apnoea (CSA)
Figure 1 Example of Central Sleep Apnea with Cheyne–Stokes Respiration
Figure 1: Example of Central Sleep Apnea with Cheyne–Stokes Respiration
Table 1 Characteristics of HF Patients with Central Sleep Apnoea
Table 1: Characteristics of HF Patients with Central Sleep Apnoea
Figure 1 Scheme for Bromocriptine Treatment of Acute PPCM at Hannover Medical School
Figure 1: Scheme for Bromocriptine Treatment of Acute PPCM at Hannover Medical School